Effect of dapagliflozin as an adjunct to insulin over 52 weeks in individuals with type 1 diabetes: post-hoc renal analysis of the DEPICT randomised controlled trials
Groop P-H, Dandona P, Phillip M, et al.
The Lancet Diabetes & Endocrinology. 2020;8(10):845-54
Leggi


